| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 04/20/2005 | EP1523328A2 Methods and compositions for inhibiting hiv replication |
| 04/20/2005 | EP1523307A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 04/20/2005 | EP1523239A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes |
| 04/20/2005 | EP1383494A4 Compositions and methods for the prevention and treatment of human prostate cancer |
| 04/20/2005 | EP1357951B1 A medical dressing comprising an antimicrobial silver compound |
| 04/20/2005 | EP1001685B1 Nutritional compositions containing methionine |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1607948A Composition comprising paracetamol and a bitterness masking component |
| 04/20/2005 | CN1197611C Medicine for treating choleithiasis and preparing method thereof |
| 04/20/2005 | CN1197602C External medicine for treating sterility and women's diseases and its prepn |
| 04/20/2005 | CN1197600C Medicine for curing haemorrhoids |
| 04/20/2005 | CN1197592C Pure traditional Chinese medicinal preparation for treating child's epilepsy disease and its preparing method |
| 04/20/2005 | CN1197588C Externally applied agent for treating skin suppuration infection |
| 04/20/2005 | CN1197584C Pourable alginate compositions |
| 04/20/2005 | CN1197563C Compound composition for curing male's sterility |
| 04/20/2005 | CN1197552C Preparations for the application of anti-inflammatory agents |
| 04/19/2005 | US6881752 (Cr3O(O2CCH2CH3)6(H2O)3)+ used in conjuction with insulin as an antidiabetic agents as well as for cardiovascular disorders; activates insulin-dependent tyrosine protein kinase activity of insulin receptor approximately eightfold |
| 04/19/2005 | US6881751 Medicament containing platinum complex compounds and the use thereof |
| 04/19/2005 | US6881750 Potassium taurate bicarbonate and ascorbate |
| 04/19/2005 | US6881731 Enhancers for microbiological disinfection |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881419 Vitamin formulation for enhancing bone strength |
| 04/19/2005 | US6881397 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 04/14/2005 | WO2005032635A1 Method for treating alcoholism and/or smoking |
| 04/14/2005 | WO2005032480A2 Methods, compositions,, apparatuses containing tetrameric oxygen |
| 04/14/2005 | WO2005032466A2 Calcium phosphate-based materials containig zinc, magnesium, fluoride and carbonate |
| 04/14/2005 | WO2005032456A2 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production |
| 04/14/2005 | WO2005032387A2 Apparatus and method for administering a therapeutic agent |
| 04/14/2005 | WO2005032234A2 Agent for reducing ill effects of acute alcohol intoxication |
| 04/14/2005 | WO2005011734A3 Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer |
| 04/14/2005 | WO2005011639A3 Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use |
| 04/14/2005 | WO2005007174A3 Synergistic antimicrobial ophthalmic combination |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080069 comprises Potassium tetrachloroplatinate and lignohumic acid ammonium salts; nontoxic |
| 04/14/2005 | US20050080049 Applying a composition of phospholipid complexes of standardized extract of Vitis vinifera, phospholipid complexes of standardized extract of Centella asiatica, excipients, and carriers; antiwrinkling agent |
| 04/14/2005 | US20050080006 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
| 04/14/2005 | US20050079597 Antimicrobial composition |
| 04/14/2005 | US20050079231 Metabolism disorders; gastrointestinal disorders |
| 04/14/2005 | US20050079230 Chlorine dioxide gel and associated methods |
| 04/14/2005 | US20050079229 Methods, compositions and systems for the prevention and treatment of diaper rash |
| 04/14/2005 | US20050079228 Clear, stable topical compositions of clarithromycin and processes for their preparation |
| 04/14/2005 | US20050079219 having a continuous coating consisting of a single thermoplastic cellulose ether, particularly ethyl cellulose, for extended release |
| 04/14/2005 | US20050079167 Surface treated active carbon; controlling particle size, porosity |
| 04/14/2005 | US20050079148 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 04/14/2005 | US20050079135 Pharmaceutical formulation comprising lanthanum compounds |
| 04/14/2005 | US20050079123 Method and apparatus for microbial decontamination |
| 04/14/2005 | DE202005000948U1 Zusammensetzung zur Behandlung der Apnoe, des Schnarchens und von Schlafstörungen Composition for the treatment of apnea, snoring and sleep disorders |
| 04/14/2005 | DE202005000862U1 Dry composition, useful for providing nutrients required for healthy joints, with some ingredients in rapid-release form and others in slow-release form, in separate components |
| 04/14/2005 | CA2581940A1 Methods, compositions,, apparatuses containing tetrameric oxygen |
| 04/14/2005 | CA2535085A1 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production |
| 04/13/2005 | EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia |
| 04/13/2005 | EP1521598A1 Adjuvant containing xenon |
| 04/13/2005 | EP1521590A1 Novel medicament combinations based on magnesium salts and fibrinolytics |
| 04/13/2005 | EP1521579A1 Novel medicament combinations based on sodium channel blockers and magnesium salts |
| 04/13/2005 | EP1404293A4 Infection control system |
| 04/13/2005 | EP1274399B1 Liposomes containing an entrapped compound in supersaturated solution |
| 04/13/2005 | EP1196136B1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 04/13/2005 | EP1115409A4 Composition for extending post meal satiety |
| 04/13/2005 | EP1077709B1 Arsenic sulfide compounds free of arsenic oxide for the treatment of hematological cancers |
| 04/13/2005 | CN1606462A Composition based on etyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne |
| 04/13/2005 | CN1606449A Improved use of antitumoral compound in cancer therapy |
| 04/13/2005 | CN1606430A Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 04/13/2005 | CN1606406A Mitocidal compositions and methods |
| 04/13/2005 | CN1605345A Medicine for stomach disease |
| 04/13/2005 | CN1605344A Traceless stock solution(prescription) |
| 04/13/2005 | CN1196494C Medicine powder for aphtha of external use |
| 04/13/2005 | CN1196490C Externally-used paste for curing dermatitis |
| 04/13/2005 | CN1196489C Perfusion liquid preparations for ophthalmic operations |
| 04/12/2005 | US6878526 Treating cancer |
| 04/12/2005 | US6878388 Vanadium compounds for treating proliferative cell disorders |
| 04/12/2005 | US6878373 Probiotic composition containing Bacillus cereus RRRL B-30535 |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2179180C Depth-type filter for killing microorganisms and inactivating viruses and its use |
| 04/07/2005 | WO2005030653A1 Improvement in fluoridation system |
| 04/07/2005 | WO2005030263A1 Use of gas for the manufacture of a monitoring agent for diagnostic passage through the intestinal tract or exocrine function of the pancreas |
| 04/07/2005 | WO2005030262A1 Use of a gas for the manufacture of a diagnosing agent for diagnosing coronary perfusion |
| 04/07/2005 | WO2005030228A2 Use of a composition containing extracts of vitis vinifera and lycopersicum for protecting the skin |
| 04/07/2005 | WO2005030168A1 Skin burn treatment ointment |
| 04/07/2005 | WO2005030118A2 Targeted release of nitric oxide in the cns circulation for modulating the bbb and treating disorders |
| 04/07/2005 | WO2005030028A2 Methods for detecting presence of cellular constituents |
| 04/07/2005 | WO2004110383A3 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy |
| 04/07/2005 | WO2004096206A3 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor |
| 04/07/2005 | WO2004093795A3 Compositions for delivery of drug combinations |
| 04/07/2005 | WO2004071569A3 Method for preventing local radioreactions |
| 04/07/2005 | WO2004037120A3 Implantable medical devices using zinc |
| 04/07/2005 | US20050075391 Nitric oxide donor composition and method for treatment of anal disorders |
| 04/07/2005 | US20050075313 Ophthalmic compositions containing galactomannan polymers and borate |
| 04/07/2005 | US20050075276 administering peptide or non-peptide drugs that modulate the CD28 antigen inactivation of GSK-3 in lymphocytes responses against viral, bacterial, fungal or prion infections in mammals |
| 04/07/2005 | US20050074775 assessing GST-pi expression levels in fixed or fixed and paraffin embedded tissues using primers; pharmacogenetics; determining antitumor platinum-based chemotherapeutic regimen |
| 04/07/2005 | US20050074506 Applying energy to blood brain barrier (BBB) region to break encapsulation; activating facilitator to promote passage of therapeutic and/or diagnostic agent |
| 04/07/2005 | US20050074505 Reduced heat of hydration in wound area; adjusted calcium content; one step treatment; rapid clotting; minimizing discomfort |
| 04/07/2005 | US20050074503 Applying brilman's solution; preventing HIV/AIDS diseases, gripe and flu |
| 04/07/2005 | US20050074501 Creating sterile, stable, high concentration ozone rapidly on demand; herniated discs; inflammatory and degenerative disease |
| 04/07/2005 | US20050074412 especially for endoscopic surgery, comprising a rinsing fluid and nitrous oxide added as a marker in an amount detectable in the expired breath from a mammal, especially man, that is subjected to the surgery. |
| 04/07/2005 | US20050072272 Combustion of mixed gas of oxygen and hydrogen in high pressure water; melting titanium in combustion gas; health, cosmetics and medical equipment utilize physiologically activating effect; water electrolysis apparatus for generating the mixed gas |
| 04/07/2005 | DE19912850B4 Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung Solution, in particular for hemodialysis or peritoneal dialysis, as well as processes for their preparation |
| 04/07/2005 | DE10346083A1 Pulverförmige Zusammensetzung zur Verwendung als Laxativum Pulverulent composition for use as a laxative |
| 04/07/2005 | DE10342449A1 Verwendung von Sauerstoff in kosmetischen oder dermatologischen Zubereitungen Use of oxygen in the cosmetic or dermatological preparations |
| 04/07/2005 | DE10342258A1 Antimicrobial composition for topical application for pharmaceutical or cosmetic purposes comprises elemental silver nanoparticles deposited on an inert support |
| 04/06/2005 | EP1520584A1 Composition for the activation of the immune system |